Raymond James & Associates’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $17.1K | Hold |
|
|||||
|
2024
Q2 | $18.3K | Buy |
|
|||||
|
2024
Q1 | $26K | Hold |
|
|||||
|
2023
Q4 | $16.6K | Hold |
|
|||||
|
2023
Q3 | $11.8K | Sell |
|
|||||
|
2023
Q2 | $25.4K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $416K | Sell |
|
|||||
|
2017
Q2 | $573K | Buy |
|
|||||
|
2017
Q1 | $451K | Buy |
|
|||||
|
2016
Q4 | $420K | Buy |
|
|||||
|
2016
Q3 | $510K | Buy |
|
|||||
|
2016
Q2 | $315K | Sell |
|
|||||
|
2016
Q1 | $263K | Buy |
|